Clinitech Laboratory Ltd
Clinitech Lab | 544220
Share Price Chart - Clinitech Laboratory Ltd
Stock Performance
Ratios
Consolidated data not available
Please try selecting a different data type
About Company
- Clinitech Laboratory Limited was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 with the Registrar of Companies, Mumbai
- The status of Company was changed to Public Limited and the name of Company changed to Clinitech Laboratory Limited through fresh certificate of incorporation upon conversion on August 25, 2023 was issued by the Registrar of Companies, Mumbai
- Company is in the business of healthcare services providing superior quality services such as pathology testing laboratories, diagnostic centers, scan centers, X-ray and ECG clinics, etc
- The Company established a new Lab in Kalyan in 2012, NABL Accreditation at Airoli Centre in 2016, a new Lab at Thane in 2018
- Besides these, the Company conduct more than 150 tests including Biochemistry, Immunology, Hematology, Molecular Biology tests, urine analysis, Serology, Microbiology and Histopathology tests
- Clinical pathology is a medical specialty that focuses on the diagnosis of diseases and conditions through the analysis of bodily fluids and tissues
- It includes various laboratory tests and techniques such as blood tests, urine analysis, and tissue biopsies to help healthcare professionals understand the underlying causes of a patient's symptoms and guide treatment decisions
- Clinical pathologists play a crucial role in interpreting test results and providing valuable information to aid in patient care
- Imaging diagnosis or radiology involves imaging procedures such as X-rays and ultrasounds that help determine anatomical or physiological changes inside a patient's body, thus assisting doctors in diagnosing
- It includes more complex tests such as CT scans, MRIs, and highly specialized PET-CT scans
Research Calls
Technical Indicators
Pivot Points
No Information Available
Volume Analysis data is not available at this time.
No Information Available
Growth Rate information is not available at this time.
All figures in ₹ Crores
No Information Available
No profit & lossdata available
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Top Gainers
Frequently Asked Questions
What is Share Price of Clinitech Laboratory Ltd?
The current share price of Clinitech Laboratory Ltd (Clinitech Lab) is ₹40.00. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Clinitech Laboratory Ltd?
The Price-to-Earnings (P/E) ratio of Clinitech Laboratory Ltd is 40.00. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Clinitech Laboratory Ltd?
Clinitech Laboratory Ltd has a 52-week high of ₹57.00 and a 52-week low of ₹28.55. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Clinitech Laboratory Ltd?
Clinitech Laboratory Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Clinitech Laboratory Ltd?
The Earnings Per Share (EPS) of Clinitech Laboratory Ltd is ₹1.83. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Clinitech Laboratory Ltd?
Clinitech Laboratory Ltd has a Return on Equity (ROE) of 5.49%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
